Profile
LMDX DHR-PB TMO DHR IDXX A
Company Name LumiraDx Limited Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $5.10M $916.76B $203.95B $153.12B $51.47B $36.74B
Employees 1.21K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Veronique Ameye EMBA, Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
LMDX DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
LMDX DHR-PB TMO DHR IDXX A
Last Close $0.016 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $0.02 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.02 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -20 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low -20 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
LMDX DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 0 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 0 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 0 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 0 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 0 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LMDX DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) -6.49 % 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Growth
LMDX DHR-PB TMO DHR IDXX A
Asset Growth -31.6 % 7.64 % 13.38 % 7.64 % 1.03 %
Gross Profit Growth -123.3 % 5.38 % -5.36 % 5.38 % 8.63 %
Revenue Growth -39.62 % 2.9 % 3.91 % 2.9 % 6.46 %
Revenue 3 Year 884.53 % -5.47 % 3.42 % -5.47 % 25.23 %
Revenue 5 Year 884.53 % 10.08 % 45.65 % 10.08 % 69.09 %
Revenue 10 Year 884.53 % 68 % 178.48 % 68 % 218.38 %
EBIT Growth -1631.69 % -7.15 % -6.71 % -7.15 % 3.47 %
Net Income Growth -345.79 % -7.31 % 6.35 % -7.31 % 5.07 %
Net Income 3 Yeari Growth Per Share -202.14 % -48.61 % 1.06 % -48.61 % 23.15 %
Net Income 5 Yeari Growth Per Share -202.14 % -1.03 % 11.3 % -1.03 % 116.76 %
Net Income 10 Yeari Growth Per Share -202.14 % 37.36 % 261.63 % 37.36 % 492.42 %
Operating Income Growth -1705.39 % -0.91 % 5.83 % -0.91 % 2.84 %
Operating Cash Flow Growth (CFG) -20.18 % -4.07 % -9.8 % -4.07 % 2.48 %
Operating 3 Year CFG -58.18 % -22.79 % -10.96 % -22.79 % 27.03 %
Operating 5 Year CFG -58.18 % 3.19 % -0.67 % 3.19 % 111.28 %
Operating 10 Year CFG -58.18 % 66.57 % 194.29 % 66.57 % 378.1 %
EPS Growth -297.5 % -4.88 % 7.18 % -4.88 % 5.9 %
EPS Diluted Growth -156.45 % -4.73 % 7.32 % -4.73 % 6.06 %
Book Value Per Share -158.02 % 9.57 % 9.5 % 9.57 % 8.24 %
Share Holder 3 Year Equity Growth Per Share 38.35 % 7.54 % 26.63 % 7.54 % 138.87 %
Share Holder 5 Year Equity Growth Per Share 38.35 % 31.9 % 63.03 % 31.9 % 838.67 %
Share Holder 10 Year Equity Growth Per Share 38.35 % 118.87 % 165.29 % 118.87 % 1547.69 %
Dividend Per Share Growth - 18.15 % 10.83 % 18.15 % -
Dividend 3 Year Growth Per Share - 10.04 % 45.73 % 10.04 % -
Dividend 5 Year Growth Per Share - 42.54 % 98.76 % 42.54 % -
Dividend 10 Year Growth Per Share - 144.73 % 180.3 % 144.73 % -
Debt Growth 19.37 % 7.42 % 20.17 % 7.42 % -7.53 %
Free Cash Flow Growth 22.44 % -0.68 % -13.4 % -0.68 % 3.26 %
Updated On 31 Dec 2022 31 Dec 2025 31 Dec 2025 31 Dec 2025 31 Dec 2024
Profitability
LMDX DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM -13.87 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -101.86 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM -1557.76 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -92.05 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 101.33 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 137.9 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -126.32 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM -40.4 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Receivables Turnover TTM 3.9 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 10.03 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM 3.22 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 195.77 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 57.7 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM -0.57 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM -0.66 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 35.43 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM -63.7 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 115.41 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM -40.4 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Price To Free Cash Flows Ratio TTM -0.03 29.11 32.41 29.11 48.69 31.89
Price To Operating Cash Flows Ratio TTM -0.03 23.88 26.11 23.88 43.69 23.52
Price Cash Flow Ratio TTM -0.03 23.88 26.11 23.88 43.69 23.52
Income Statement (TTM)
LMDX DHR-PB TMO DHR IDXX A
Revenue $0.25B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $-0.04B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio -13.87% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.27B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.45B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -1.59 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
LMDX DHR-PB TMO DHR IDXX A
Long Term Debt $0.38B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0.55B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $-0.11B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0.01B $0B $0.25B $0B $0B $0.13B
Total Debt $0.4B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.44B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
LMDX DHR-PB TMO DHR IDXX A
Net Income $-0.45B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $-0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0.16B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0.02B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 127.51
ACRS Aclaris Therapeutics, Inc. 3.695
ADVB Advanced Biomed Inc. Common Stock 0.243
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10
BIAF bioAffinity Technologies, Inc. 0.9025
BIAFW bioAffinity Technologies, Inc. 0.25
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 92.59
BNGO Bionano Genomics, Inc. 1.15
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 30.91
CDNA CareDx, Inc 20.2
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 185.74
ETFs With Exposure to LMDX
Ticker ETF Name Weight Percentage Price
SPAK Defiance Next Gen SPAC Derived ETF 0.04 14.63
Unlock